Literature DB >> 30030263

Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications.

Samuel Bitoun1, Corinne Miceli-Richard1, Céline Verstuyft2, Pierre Antoine Juge3, Philippe Dieudé3, Jean-Marie Berthelot4, Christophe Richez5, Cécile Cauquil6, Christelle Sordet7, Sylvie Melac-Ducamp8, Laure Gossec9,10, Beatrice Bouvard11, Emmanuelle Dernis12, Eric Houvenagel13, Marie-Astrid Boutry-Bacle14, Xavier Mariette1, Raphaèle Seror1.   

Abstract

Entities:  

Keywords:  ankylosing spondylitis; anti-tnf; gene polymorphism; rheumatoid arthritis; treatment

Mesh:

Substances:

Year:  2018        PMID: 30030263     DOI: 10.1136/annrheumdis-2018-213183

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  1 in total

1.  Tumor necrosis factor alpha inhibitors and demyelinating disease: what is behind it?

Authors:  Eugeniusz Józef Kucharz; Anna Kotulska-Kucharz
Journal:  Reumatologia       Date:  2021-04-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.